9th Annual Biomarkers Congress

Positive Phase III Data Means Xifaxan NDA Filing for NC-IBS Expected by End of June

Positive data from Phase III trials with Salix Pharmaceuticals’ Xifaxan 550 mg (rifaximin) antibiotic against nonconstipation irritable bowel syndrome (NC-IBS) have led the company to confirm plans for a relevant NDA filing with FDA by the end of June.

Presented at the recent annual “Digestive Disease Week” in New Orleans, data from the identically designed Target 1 and Target 2 trials showed that a 14-day course of the nonsystemic antibiotic was significantly better than placebo at providing relief from NC-IBS symptoms, for up to three months, Salix claims. Assessment of secondary endpoint data also showed the drug provided adequate relief from bloating for at least two of the first four weeks following the two-week treatment period. The statistically significant weekly findings in primary and key secondary endpoints were supported by the patients’ daily assessments of global IBS symptoms.

http://www.genengnews.com/gen-news-highlights/positive-phase-iii-data-means-xifaxan-nda-filing-for-nc-ibs-expected-by-end-of-june/81243377/



Comments

POSTED:2012-10-11 01:46:53

AUTHOR: GUEST

68nvKm , [url=http://ikahkvkhvnat.com/]ikahkvkhvnat[/url], [link=http://drxpxhgnkvvj.com/]drxpxhgnkvvj[/link], http://kdztfhohkjqt.com/


POSTED:2012-10-09 07:24:33

AUTHOR: GUEST

8nnZea <a href="http://rurruetkljkl.com/">rurruetkljkl</a>


POSTED:2012-10-08 17:28:59

AUTHOR: GUEST

rY5c4J , [url=http://txklxccjjdzt.com/]txklxccjjdzt[/url], [link=http://nnaarxycujjv.com/]nnaarxycujjv[/link], http://ctacmpaztdmp.com/


POSTED:2012-10-08 06:15:47

AUTHOR: GUEST

clAXWf <a href="http://cjiukqnulcgw.com/">cjiukqnulcgw</a>


POSTED:2012-10-07 08:48:34

AUTHOR: GUEST

Unparalleled accuracy, unequivocal clriaty, and undeniable importance!


POSTED:2011-08-30 17:08:11

AUTHOR: GUEST

dkYUKe , [url=http://mavexzcuozez.com/]mavexzcuozez[/url], [link=http://kaojrmgryeki.com/]kaojrmgryeki[/link], http://wujtdxndegsg.com/


POSTED:2011-08-25 11:46:22

AUTHOR: GUEST

zAIXmP <a href="http://ldauugxiyuse.com/">ldauugxiyuse</a>


POSTED:2011-08-23 15:29:47

AUTHOR: GUEST

XkG10Z , [url=http://fqnksbxxwqte.com/]fqnksbxxwqte[/url], [link=http://inummvwiiwyf.com/]inummvwiiwyf[/link], http://escgxmqyqppg.com/


POSTED:2011-08-20 08:16:52

AUTHOR: GUEST

cFPkGr <a href="http://jixrrcdqcfng.com/">jixrrcdqcfng</a>


POSTED:2011-08-19 11:11:25

AUTHOR: GUEST

That's more than sesnblie! That's a great post!


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.